Ratings by B.Riley (William Wood)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2026 | Alpha Cognition Inc | ACOG | New Coverage | Buy (N/A) |
8.57 (9.17) |
7% | Details | |
| 7/23/2026 | Agomab Therapeutics | AGMB | New Coverage | Buy (N/A) |
11.60 (13.54) |
16.72% | Details | |
| 6/5/2026 | iBio, Inc. | IBIO | New Coverage | Buy (N/A) |
1.93 (1.26) |
-34.72% | Details | |
| 5/22/2026 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2026 | Equillium | EQ | New Coverage | Buy (N/A) |
2.05 (2.21) |
7.8% | Details | |
| 3/24/2026 | Aardvark Therapeutics Inc | AARD | Maintain | Buy (N/A) |
|
Details | ||
| 1/28/2026 | Aardvark Therapeutics Inc | AARD | New Coverage | Buy (N/A) |
14.76 (5.92) |
-59.89% | Details | |
| 1/9/2026 | Palisade Bio Inc. | PALI | New Coverage | Buy (N/A) |
2.02 (1.96) |
-2.97% | Details | |
| 12/7/2025 | OKYO Pharma Ltd. | OKYO | New Coverage | Buy (N/A) |
2.01 (1.51) |
-24.88% | Details | |
| 9/2/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2024 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
1.46 (14.58) |
898.63% | Details | |
| 8/8/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2024 | Veru, Inc. | VERU | New Coverage | Buy (N/A) |
1.33 (2.69) |
102.26% | Details | |
| 3/12/2024 | LifeMD Inc | LFMD | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2023 | Koru Medical Systems Inc. | KRMD | New Coverage | Buy (N/A) |
2.30 (3.30) |
43.48% | Details | |
| 12/1/2023 | Clearpoint Neuro Inc. | CLPT | New Coverage | Buy (N/A) |
5.76 (14.90) |
158.68% | Details | |
| 12/1/2023 | LifeMD Inc | LFMD | New Coverage | Buy (N/A) |
7.70 (3.10) |
-59.74% | Details |
